Search results

When US President Barack Obama declared in his 2009 inaugural address, "We will restore science to its rightful place," many applauded. The US has led the world in research, innovation, and education in the medical sciences. The National Science Foundation, the NIH, and other government organizations involved in scientific investigations are the primary engines that have fueled this excellence over the past half century. Nevertheless, we cannot afford to assume that preeminence, or even excellence, will persist without attention and cultivation.

Offers an analytical tool that measures reinvestment rate risk.
Expands the knowledge of the concept of reinvestment vis‐...‐vis the
internal rate of return via the external rate of return. Concludes that
investors should prefer investments that are less sensitive to
reinvestment rate assumption than vice versa.

This book examines justice reinvestment from its origins, its potential as a mechanism for winding back imprisonment rates, and its portability to Australia, the United Kingdom and beyond. It argues for a community-driven approach, originating in vulnerable Indigenous communities with high imprisonment rates.

AbstractThis article examines firms' motivations for offering investors the opportunity to purchase initial shares of stock directly from the company by joining the firm's dividend reinvestment plan (DRP). The results of both a telephone survey of Investor Relations Departments and analysis of plan prospectuses indicate that firms offer such no‐load DRPs with the objective of broadening their shareholder base. Moreover, additional analysis shows that firms which implement no‐load DRPs subsequently experience a significant decrease in the number of shares held per shareholder. Thus, no‐load DRPs do appear to be successful in broadening a firm's shareholder base.